LIFE Foundation Announces 2008 realLIFEstories Award Recipients to Illustrate Benefits of Life and Disability... (rg . About Life Insurance Awareness M...)

(Date:11/21/2008)...21 U.S. News & Worl...surance (NCQA) ranked BlueChoice(R) HealthPlan of ...Health Plans(TM), published in U.S. News & Wor...ted annual ranking ranks the nation,s best health ...on and NCQA accreditation scores. NCQA and U.S. Ne...

(Date:11/21/2008)... Nov. 21 Today, prescrip...ention in treating 88 percent of patients sufferin... treated for a chronic condition account for 96 pe...cent of all medical costs. A proprietary new phar...lth Solutions, Inc. (NYSE: MHS ) significantly r...

(Date:11/21/2008)... drugs do not cause genetic damage that can lead t... News) -- Two popular medications for treating att...t cause genetic damage linked to an increased risk... study, done by researchers at Duke University Med... counters a previous one that reported biomarkers ...

(Date:11/21/2008)...and deadly diseaseits cause remains a mysteryswept...ing with citizens, soldiers and refugees of the wa...s filled with corpses, social order broke down. Ov...e and Athens lost a third of its population. It lo...ginning of the end of the Golden Age of Greece. ,...

Breaking Medicine News(10 mins):Health News:BlueChoice HealthPlan Ranks in Top Third of America's Best Health Plans 2 Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 2 Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 3 Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 4 Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 5 Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 6 Health News:ADHD Medications Don't Pose Cancer Risk 2 Health News:Study of ancient and modern plagues finds common features 2 Health News:Study of ancient and modern plagues finds common features 3 Health News:Study of ancient and modern plagues finds common features 4

[0] BlueChoice HealthPlan Ranks in Top Third of America's Best Health Plans [0] New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes [0] ADHD Medications Don't Pose Cancer Risk [1] Study of ancient and modern plagues finds common features

...ing a panic disorder may benefit more from treatme...ication instead // of the care usually offered by ...bling and costly anxiety disorders. In the study, ...nic disorder were randomly assigned to receive tre...

...t forgotten the thalidomide tragedy thalidomide in...tment of morning sickness // to pregnant mothers a.... Now, doctors see a new future use for the infamo...maintain their weight. The effects of this drug we...

...dy in Journal of Dental Research, caries in primar...nt teeth.// A primary tooth can have caries for a...alth or history, socio-economic status, years of e...ce to primary teeth, and early loss of primary tee...

...e of Journal of American Medical Association, rese...growing// trend in delaying the vaccination schedu...of the vaccinated diseases affecting the children....of the vaccines that need to be completed during t...

Other Medicine News:

Panic Disorder Can Be Handled Better Old Drugs Safe To Use In Cancer Treatment ?Is caries in primary and permanent tooth related?Growing trend of delay in completing vaccination schedule

(Date:11/19/2008)...ent from Roche- , , MONTVALE, N.J., Nov. 19...Corp. (Nasdaq: MEMY ) today announced that it ha...al of R3487/MEM 3454, its lead alpha-7 nicotinic r...d with schizophrenia (CIAS). The Company has rand...ng a $5.0 million payment from its partner Roche. ...

(Date:11/18/2008)...Newswire/ -- Arlington Medical Resources (AMR), a,...harmaceutical and diagnostic,imaging industries, ...gen was,sold in the U.S. during the third quarter...nous immune globulin (IVIG) and was launched in th...d from the blood plasma of thousands,of donors an...

(Date:11/18/2008)...oll newly diagnosed, elderly AML patients , ,...r Pharmaceuticals today announced that the first p...inical study of CPX-351 (Cytarabine:Daunorubicin) ...d acute myeloid leukemia (AML). , , The fir... Weill Medical College of Cornell University and...

(Date:11/13/2008)...ch Finds Statins Cut Risk of Heart Attacks, Deaths... Cardiovascular Disease,is the leading cause of de... hundreds of millions of dollars and causing untol...this fatal disease - even among those who,weren,t ...t millions of people could cut their risk of a,hea...

Breaking Medicine Technology:Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2 Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 3 Over $10 Million of CSL Behring's Privigen Was Sold in the U.S. During the Third Quarter of 2008 2 Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 2 Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 3 Seniors Can Be Heartened by New Study on Statins 2 Independence Blue Cross and The Childrens Hospital of Philadelphia Reach Seven Year Agreement 13453 1 Independence Blue Cross and The Childrens Hospital of Philadelphia Reach Seven Year Agreement 13453 2 Independence Blue Cross and The Childrens Hospital of Philadelphia Reach Seven Year Agreement 13453 3 Autism Society of America Hosts Day on the Hill 13449 1 Autism Society of America Hosts Day on the Hill 13449 2 Rare Gene Mutation Plays Role in Longevity 13445 1 Rare Gene Mutation Plays Role in Longevity 13445 2 Rare Gene Mutation Plays Role in Longevity 13445 3 Women are treated less frequently than men with statins aspirin and beta blockers 13441 1 Women are treated less frequently than men with statins aspirin and beta blockers 13441 2

[0] Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia [0] Over $10 Million of CSL Behring's Privigen Was Sold in the U.S. During the Third Quarter of 2008 [0] Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 [1] Seniors Can Be Heartened by New Study on Statins

...INCETON, N.J., June 14, 2007 /PRNewswire-FirstCall...tical company,committed to discovering, developing...fections, announced today that scientific,data pre...uring the,16th International HIV Drug Resistance W...une 12-15, 2007. The poster presentations,are avai...

...RCELONA, Spain, June 15, 2007 /PRNewswire-FirstCal... results regarding the,efficacy and safety of OREN... ongoing investigational study in children with ju...inadequate response to,one or more disease-modifyi...exate (MTX) or tumor necrosis factor (TNF) antagon...

Other Medicine Technology:Pharmasset Presents Clevudine and Racivir Data at the International,HIV Drug Resistance Workshop 2 Pharmasset Presents Clevudine and Racivir Data at the International,HIV Drug Resistance Workshop 3 Pharmasset Presents Clevudine and Racivir Data at the International,HIV Drug Resistance Workshop 4 Pharmasset Presents Clevudine and Racivir Data at the International,HIV Drug Resistance Workshop 5 Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 2 Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 3 Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 4 Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 5 Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 6

Pharmasset Presents Clevudine and Racivir Data at the International,HIV Drug Resistance Workshop Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy

...iol (E2) is the most potent, naturally secreted es...vary [1]. In the ovary, estradiol is produced from...nt estrogen derived from androstenedione. Estrone ...ues. In men, small amounts of estradiol are produc...

Innotrac Aio! 2nd generation cardiac troponin I assay is a highly sensitive immunoassay providing quantitative results directly from whole blood in less than 18 minutes. The assay is based on a uniqu

...TROS ECi brings true automation and continuous ran...g. Highly sensitive assays for thyroid, anemia, ca...one metabolism testing are currently available, wi...e VITROS ECi can simultaneously process 60 accessi...

...TE 2500 is a high-throughput immunoassay system bu...IMMULITE 2000 with the important addition of Logic... assays to be designed for optimal performance wit...llows for critical assays such as the cardiac biom...

Medicine Products:

3rd Generation Estradiol RIA Test Innotrac Aio! 2nd Generation Troponin I Assay Troponin I Assay for the VITROS Eci IMMULITE 2500 STAT Troponin I

LIFE Foundation Announces 2008 realLIFEstories Award Recipients to Illustrate Benefits of Life and Disability...(rg . About Life Insurance Awareness M...),Health